CD36 deficiency under atherogenic conditions not only significantly alters the ATM dynamics (Figure 3B), but also decreases adipocyte hypertrophy (Figures 3E,F), which is associated with adipose tissue dysfunction and metabolic disease (85). Here, CD36 is linked to metabolic disease.